Don and Karen Cohn Give $2.5 Million to UC San Diego Health Neurosurgery Program (external site)
After experiencing a medical emergency, Don Cohn is giving back to the department that he credits with saving his life.
UC San Diego Health News
UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.
The Latest
Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus? (external site)
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.
Do a Mom’s Medications Affect Her Breast Milk and Baby? New Center Investigates (external site)
UC San Diego School of Medicine receives $6.1M to launch a new research center studying the effects of maternal antibiotic use on breast milk and infant health. The center is funded by National Institutes of Health, as part of their new Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub.
Diet Plays Critical Role in NASH Progressing to Liver Cancer in Mouse Model (external site)
Researchers at UC San Diego School of Medicine found in a mouse model that when fed a Western diet rich in calories, fat and cholesterol, the mice progressively became obese, diabetic and developed NASH, which progressed to HCC, chronic kidney and cardiovascular disease.
Despite COVID-19 Pandemic First Patient Undergoes New Personalized Immunotherapy (external site)
Bernard Thurman was referred to a personalized cancer therapy trial at Moores Cancer Center at UC San Diego Health, a collaboration with the La Jolla Institute for Immunology, the trial employs a patient’s immune cells — specifically tumor infiltrating lymphocytes (TIL) — to destroy cancer cells.
Current Clinical Trial Assessing Potential of CBD in Treatment of Autism (external site)
Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.
In the Media
UC San Diego 1st to offer radiation ‘bandage’ for skin cancer
Becker's Hospital Review, September 24
126 hospitals with Magnet with Distinction status
Becker's Clinical Leadership, September 28
Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
STAT News, September 29
UC San Diego Health among first to use new technology for brain bleeds
FOX 5/KUSI, September 30
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
